CBOE · CBTG
Cabot Growth ETF
$14.75-$0.01 (-0.07%)
Cabot Growth ETF’s quoted price sits in the lower half of its reported 52-week range, 54.15% below the high.
Loading market information…
AMEX · CSH · USD
Stock price
Quote as of Apr 11, 2023, 05:08 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Morgan Creek-Exos Active SPAC Arbitrage ETF’s quoted price sits in the upper half of its reported 52-week range, 1.93% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
This fund's primary strategy involves investing in U.S.-listed Special Purpose Acquisition Companies (SPACs) during typical market conditions. Specifically, it targets the units offered by these entities, which commonly comprise common stock, warrants, and associated rights. A SPAC itself is a blank check entity with no commercial operations of its own. Its sole purpose is to raise capital through an Initial Public Offering (IPO) in order to eventually acquire, merge with, or otherwise combine with an existing operating business. A substantial portion of the fund's net assets—at least 80% under normal circumstances—is strategically directed towards these Pre-Combination SPACs, meaning those that have not yet identified or completed a merger target. Investors should also be aware that this fund operates on a non-diversified basis.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Nov 1, 2026, 05:57 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
KEEP COMPARING
$14.75-$0.01 (-0.07%)
Cabot Growth ETF’s quoted price sits in the lower half of its reported 52-week range, 54.15% below the high.
$20.09+$0.01 (+0.02%)
AAM S&P Emerging Markets High Dividend Value ETF’s quoted price sits in the upper half of its reported 52-week range, 1.23% below the high.
$53.58-$1.95 (-3.51%)
ETRACS Alerian Midstream Energy Index ETN’s quoted price sits in the upper half of its reported 52-week range, 3.76% below the high.
$8.17+$0.04 (+0.52%)
Global X Fertilizers/Potash ETF’s quoted price sits in the upper half of its reported 52-week range, 2.57% below the high.
$28.27-$0.15 (-0.53%)
Innovator IBD ETF Leaders ETF’s quoted price sits in the upper half of its reported 52-week range, 5.04% below the high.
$29.87-$0.02 (-0.07%)
Defiance Nasdaq Junior Biotechnology ETF’s quoted price sits in the lower half of its reported 52-week range, 27.94% below the high.
$19.98+$0.13 (+0.65%)
Euclid Capital Growth ETF’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$41.93+$0.06 (+0.13%)
ProShares Managed Futures Strategy ETF’s quoted price sits in the upper half of its reported 52-week range, 0.19% below the high.
